Want to join the conversation?
$ENDP said that it has extended its US marketing rights for nonsteroidal anti-inflammatory drug Voltaren Gel (diclofenac sodium topical gel) 1%, which is used for treating arthritis pain. $ENDP also entered into a 7-year deal with Sandoz & $NVS, in which $ENDP will make additional payments & double-digit royalties on net sales of Voltaren Gel.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?